Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Del Prete

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Heliyon|May 8, 2023
Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legsL Bosco, T Russo, Y M Falzone, et al.
Heliyon|July 24, 2023
Corrigendum to "Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs" [Heliyon 9(4) (April 2023) e15047]L Bosco, T Russo, Y M Falzone, et al.
Brain Imaging and Behavior|October 6, 2016
The influence of interoceptive awareness on functional connectivity in patients with irritable bowel syndromeMariachiara Longarzo, M Quarantelli, M Aiello, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|July 1, 1995
[Therapy of neonatal infection caused by group B beta-hemolytic Streptococcus]A Aabas, M Berzioli, P Brisotto, et al.
American Journal of Clinical Oncology|June 1, 1994
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimenJ R Murren, H J Durivage, A H Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.
Gynecologic Oncology|July 10, 2012
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinomaUrsula A Matulonis, Sudarshan Sharma, Sharad Ghamande, et al.
European Journal of Immunology|March 10, 2001
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivoM Vulcano, C Albanesi, A Stoppacciaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2013
Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyC Fotopoulou, I Vergote, P Mainwaring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerMitesh J Borad, Shantan G Reddy, Nathan Bahary, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Heliyon|May 8, 2023
Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legsL Bosco, T Russo, Y M Falzone, et al.
Heliyon|July 24, 2023
Corrigendum to "Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs" [Heliyon 9(4) (April 2023) e15047]L Bosco, T Russo, Y M Falzone, et al.
Brain Imaging and Behavior|October 6, 2016
The influence of interoceptive awareness on functional connectivity in patients with irritable bowel syndromeMariachiara Longarzo, M Quarantelli, M Aiello, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|July 1, 1995
[Therapy of neonatal infection caused by group B beta-hemolytic Streptococcus]A Aabas, M Berzioli, P Brisotto, et al.
American Journal of Clinical Oncology|June 1, 1994
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimenJ R Murren, H J Durivage, A H Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.
Gynecologic Oncology|July 10, 2012
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinomaUrsula A Matulonis, Sudarshan Sharma, Sharad Ghamande, et al.
European Journal of Immunology|March 10, 2001
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivoM Vulcano, C Albanesi, A Stoppacciaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2013
Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyC Fotopoulou, I Vergote, P Mainwaring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerMitesh J Borad, Shantan G Reddy, Nathan Bahary, et al.
Pageof 7